CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS

CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS

Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatment options. Materials and methods. Two models for...

Full description

Bibliographic Details
Main Authors:	E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2016-02-01
Series:	Фармакоэкономика
Subjects:	idiopathic thrombocytopenic purpura (itp) cost-minimization analysis budget impact analysis thrombopoietin receptor agonist (tpo-ra) eltrombopag romiplostim
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/130

Similar Items

Review article: THE ROLE OF ELTROMBOPAG AND ROMIPLOSTIM AS THE THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) IN TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP): WHAT IS TPO-RA, WHEN TPO-RA IS USED AND HOW TO TAKE TPO-RA?
by: Jefri Pratama Susanto
Published: (2016-11-01)

Pharmacoeconomic analysis of thrombopoietin receptor agonists in the treatment of chronic idiopathic thrombocytopenic purpura in adults
by: E. A. Pyadushkina, et al.
Published: (2018-06-01)

Pharmacoeconomic Analysis of the Use of Thrombopoietin Receptors Agonists in Idiopathic Thrombocytopenic Purpura Therapy
by: VA Shuvaev, et al.
Published: (2017-10-01)

Clinical statistics and effectiveness of different treatments of idiopathic thrombocytopenic purpura
by: Lidiya Grigor'evna Kovaleva, et al.
Published: (2011-04-01)

An Ischemic Stroke Related to Eltrombopag Use in a Patient with Idiopathic Thrombocytopenic Purpura
by: Demet Arslan, et al.
Published: (2016-03-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice
by: V V PTUSHKIN, et al.
Published: (2018-07-01)

Thrombopoietin Receptor Agonists in Treatment of Idiopathic Thrompocytopenic Purpura (Primary Immune Thrombocytopenia): Efficacy and Safety in Everyday Clinical Practice
by: II Zotova, et al.
Published: (2017-01-01)

Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report
by: Kouki Hoshino, et al.
Published: (2019-04-01)

Use of thrombopoietin receptor agonists in childhood immune thrombocytopenia
by: Angelica Maria Garzon, et al.
Published: (2015-08-01)

Toxic interactions of Romiplostim and Rituximab in normal and thrombocytopenic Rats
by: Saeed H., et al.
Published: (2020-01-01)

A Survey of 121 patients with Idiopathic Thrombocytopenic Purpura
by: A Shahriariahmadi, et al.
Published: (2005-06-01)

A Survey of 121 patients with Idiopathic Thrombocytopenic Purpura
by: Shahriariahmadi A, et al.
Published: (2005-07-01)

Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature
by: Marco Capecchi, et al.
Published: (2021-09-01)

Idiopathic thrombocytopenic purpura: laboratory diagnosis and management
by: Alvina
Published: (2011-08-01)

Idiopathic thrombocytopenic purpura: laboratory diagnosis and management
by: Alvina Alvina
Published: (2016-02-01)

Low-Dose Eltrombopag in a Patient with Chronic Idiopathic Thrombocytopenic Purpura Post Sleeve Gastrectomy
by: Mohanad A. Ahmed, et al.
Published: (2020-06-01)

Chronic subdural hematoma associated with idiopathic thrombocytopenic purpura in an elderly female
by: Sachin Chhabra, et al.
Published: (2016-09-01)

Sertraline Induced Bruises in a Patient with Separation Anxiety Disorder and Familial Idiopathic Thrombocytopenic Purpura: A Case Report
by: Reza Bidaki, et al.
Published: (2018-12-01)

Evaluation of 143 Cases of Immune Thrombocytopenic Purpura With Regards to Clinical Course and Response to Treatment
by: Murat Albayrak, et al.
Published: (2010-12-01)

An Idiopathic Thrombocytopenic Purpura Patient Treated With Homeopathy: A Case Report
by: Belinda Gousta, et al.
Published: (2016-05-01)

Immune Thrombocytopenic Purpura
by: Teny Tjitra Sari
Published: (2018-08-01)

Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia
by: Perdomo J
Published: (2016-02-01)

Treating ITP: What are the options in the era of new guidelines and new drugs?
by: Pantić Nikola, et al.
Published: (2020-01-01)

Renal transplant in a patient with idiopathic thrombocytopenic purpura refractory to steroid and intravenous immunoglobulin
by: Shubham Agarwal, et al.
Published: (2019-01-01)

Chemotherapy in a Patient with Prior History of Idiopathic Thrombocytopenic Purpura
by: Kouji Kanemoto, et al.
Published: (2003-01-01)

Idiopathic thrombocytopenic purpura
by: L Kayal, et al.
Published: (2014-01-01)

Acquired Amegakaryocytic Thrombocytopenic Purpura Progressing into Aplastic Anemia
by: Jan Philipp Novotný, et al.
Published: (2018-01-01)

Economic Evaluation of Rituximab + Recombinant Human Thrombopoietin vs. Rituximab for the Treatment of Second-Line Idiopathic Thrombocytopenic Purpura in China
by: Mingjun Rui, et al.
Published: (2021-03-01)

Immunomodulation in Primary Immune Thrombocytopenia: A Possible Role of the Fc Fragment of Romiplostim?
by: Alexandra Schifferli, et al.
Published: (2019-06-01)

Idiopathic thrombocytopenic purpura in women with breast cancer
by: Mozhgan Alam Samimi, et al.
Published: (2010-01-01)

Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
by: Alhossain A. Khalafallah, et al.
Published: (2012-01-01)

Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
by: Alex Shimanovsky, et al.
Published: (2016-01-01)

The Relationship between Self-esteem and Quality of Life of Patients with Idiopathic Thrombocytopenic Purpura at Isfahan's Sayed Al-Shohada Hospital, Iran, in 2013
by: Zeinab Hemati, et al.
Published: (2016-04-01)

A Case of Idiopathic Thrombocytopenic Purpura during Pregnancy
by: Maryam Moradi, et al.
Published: (2018-08-01)

Splenectomy in Idiopathic Thrombocytopenic Purpura : A Clinical Experience
by: Indro Zaeni, et al.
Published: (2019-08-01)

Laparoscopic Splenectomy for Immune Thrombocytopenic Purpura (ITP)
by: Muhammad Arham, et al.
Published: (2018-06-01)

A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia
by: Qiuhua Zhu, et al.
Published: (2021-08-01)

Idiopathic Autoimmune Thrombocytopenic Purpura (ITP) in adult; review of 50 cases admitted to Baghdad teaching hospital.
by: Adil S. Al-Aqabi, et al.
Published: (2010-07-01)

Romiplostim for thrombocytopenia following allogeneic stem cell transplantation: A case series
by: Guido Lancman, et al.
Published: (2020-09-01)